Add to ORKGMany efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pandemic, but none has yet succeeded. The lessons learned have repeatedly informed us that the traditional or conventional approaches directly using the pathogens or subunits will not be sufficient for an effective HIV/AIDS vaccine. Recent advances in structure-based technology have shown some promise in the quest for a better immunogen in HIV vaccine development. According to the basic binding structural relationship of an antigen and an antibody, structure-based antigen design could bring some hope for the development of an effective vaccine against HIV
AbstractHuman immunodeficiency virus (HIV) is the cause of one of the most lethal pandemics in human...
Despite numerous attempts over many years to develop an HIV vaccine based on classical strategies, n...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still n...
Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still n...
Introduction: The development of a human immunodeficiency virus 1 (HIV-1) vaccine remains a formidab...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
The HIV-1 pandemic remains a major public health concern worldwide with over 1.5 million new infecti...
Vaccines provide the most cost effective defense against pathogens. Although vaccines have been desi...
Vaccines provide the most cost effective defense against pathogens. Although vaccines have been desi...
Despite 30 years of study, there is no HIV-1 vaccine and, until recently, there was little hope for...
Despite 30 years of study, there is no HIV-1 vaccine and, until recently, there was little hope for...
AbstractHuman immunodeficiency virus (HIV) is the cause of one of the most lethal pandemics in human...
Despite numerous attempts over many years to develop an HIV vaccine based on classical strategies, n...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still n...
Although vaccines have proven pivotal against arrays of infectious viral diseases, there are still n...
Introduction: The development of a human immunodeficiency virus 1 (HIV-1) vaccine remains a formidab...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not ...
The HIV-1 pandemic remains a major public health concern worldwide with over 1.5 million new infecti...
Vaccines provide the most cost effective defense against pathogens. Although vaccines have been desi...
Vaccines provide the most cost effective defense against pathogens. Although vaccines have been desi...
Despite 30 years of study, there is no HIV-1 vaccine and, until recently, there was little hope for...
Despite 30 years of study, there is no HIV-1 vaccine and, until recently, there was little hope for...
AbstractHuman immunodeficiency virus (HIV) is the cause of one of the most lethal pandemics in human...
Despite numerous attempts over many years to develop an HIV vaccine based on classical strategies, n...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...